Familial Prostate Cancer
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Familial Prostate Cancer

View Main Condition: Prostate Cancer

What is the definition of Familial Prostate Cancer?
Familial prostate cancer is a cluster of prostate cancer within a family. Most cases of prostate cancer occur sporadically in people with no family history of the condition. However, approximately 5% to 10% of prostate cancer cases are believed to be primarily caused by a genetic predisposition to the condition. In many families, the underlying genetic cause is unknown; however, some of these cases are caused by changes in the BRCA1, BRCA2, HOXB13, or several other genes. Other cases are likely due to a combination of gene(s) and other shared factors such as environment and lifestyle. High-risk cancer screening at an earlier age is typically recommended in men who have an increased risk for prostate cancer based on personal and/or family histories.
What are the alternative names for Familial Prostate Cancer?
  • Familial prostate cancer
  • Hereditary prostate cancer
  • Prostate cancer, familial
  • Prostate cancer, hereditary
Who are the top Familial Prostate Cancer Local Doctors?
Elite in Familial Prostate Cancer
Elite in Familial Prostate Cancer

University Of Chicago

355 E Grand Ave, 
Chicago, IL 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Scott Eggener is a Urologist in Chicago, Illinois. Dr. Eggener is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Eggener is currently accepting new patients.

William J. Catalona
Elite in Familial Prostate Cancer
Elite in Familial Prostate Cancer
675 N St Clair St Ste 20-150, Galter Pavilion, 
Chicago, IL 
Experience:
58+ years
Languages Spoken:
English
Offers Telehealth

William Catalona is a Urologist in Chicago, Illinois. Dr. Catalona has been practicing medicine for over 58 years and is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bacterial Prostatitis, Prostatectomy, and Vasectomy.

 
 
 
 
Learn about our expert tiers
Learn More
William K. Kelly
Elite in Familial Prostate Cancer
Elite in Familial Prostate Cancer

Jefferson Cancer - Honickman Center

1101 Chestnut Street, Floor 14, 
Philadelphia, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

William Kelly is an Oncologist in Philadelphia, Pennsylvania. Dr. Kelly is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Chromophobe Renal Cell Carcinoma, Orchiectomy, and Prostatectomy. Dr. Kelly is currently accepting new patients.

What are the latest Familial Prostate Cancer Clinical Trials?
Development and Exploring the Efficacy of a Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses

Summary: This study aims to help patients with prostate cancer and their spouses cope better with the challenges of cancer by learning and supporting each other together. The investigators will test an 8-week Dyadic Co-learning Intervention, which includes weekly learning topics, a mobile app, and professional support. The goal is to improve their physical symptoms, emotional well-being, and resilience. Pa...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2 Pragmatic Clinical Trial to Evaluate Administration of Cancer Therapy in the Patients' Homes Versus in Clinic in Black Men With Advanced or Metastatic Prostate Cancer

Summary: This phase II trial evaluates the impact of cancer therapy in the patients' home compared to in the clinic on safety, side effects, patient preference, and satisfaction in Black men with prostate cancer that has spread to nearby tissue or lymph nodes (locally advanced), that has increasing prostate-specific antigen after treatment (biochemically recurrent) or that has spread from where it first st...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center